# White House strikes deals for lower prices on obesity drugs - NPR

## Metadata
| Field | Value |
|-------|-------|
| Source | NPR |
| URL | https://news.google.com/rss/articles/CBMinwFBVV95cUxOMzlfdkMyM3JyQzdQbWJDbXp3MTMwbUdzczljai1KblNxbE5TRTVJRjNSaFVfYTBoSk9Eb2FHaEpPUFdnODZlM1JzTDdZMzNQa1FWNk5UMjZYU1lmN3M4SFRqbENuTEt0MEJJaW5FdnF3bTRMVlM1Wk9zYkl6ckJjeWtZcEprYXFTS0NWZ1ZLa1o2X0xza0s5TVAyc0wtTDg?oc=5&hl=en-US&gl=US&ceid=US:en |
| Scraped | 2025-12-29 07:10 |
| Category | GLP-1|Policy |
| Relevance | 8/10 |
| Signal | bull |

## Investment Summary
White House negotiating drug pricing for obesity medications, signaling potential market expansion and regulatory impact for GLP-1 weight loss treatments.

## Key Entities
White House, Medicare, Novo Nordisk, Eli Lilly

## Dollar Amounts
None mentioned

---

## Article Content

*Full content could not be extracted. Visit URL for details.*

---

#healthcare-news #glp-1|policy #auto-scraped
